# Summary

**Deliverable:** `output/arbitrator-disclosure-issues-memo.docx` (validated, ECMA-376–consistent .docx)

## Task
Reviewed the arbitrator's disclosure statement (Hon. Margaret R. Fairhaven (Ret.), Sole Arbitrator, AAA Case No. 01-24-0003217, *Cascade Thermal Systems Inc. v. Whitmore Capital Partners LLC*) against the four other source documents — the arbitration demand, the AAA Rules excerpts, the arbitrator appointment data (xlsx), and the entity/relationship profiles — and prepared a privileged internal memorandum assessing grounds for challenge.

## What the memo does
- States the governing standards (AAA Rules R-16/R-17/R-18, AAA/ABA Code of Ethics, IBA Guidelines, FAA § 10(a)(2), *Commonwealth Coatings*).
- Sets out the procedural posture and the June 24, 2024 challenge deadline, including the R-18(f) non-waiver of undisclosed grounds.
- Identifies **five undisclosed connections** plus one incomplete disclosure, each analyzed for facts, rule implicated, direction of bias, the party most likely to raise it, and assessed strength:
  1. Indirect financial interest in Whitmore Fund II LP via the Northbridge Select Alternatives Fund (2.3% LP interest) — R-17(a)(i); Moderate (conditional).
  2. Arbitrator's husband co-authored a paper with Dr. Rita Peshkov (Claimant's key expert) on the disputed ThermalCore subject matter — R-17(a)(ii); **Strong** (best single ground; contradicts the arbitrator's stated "no professional relationship" with party employees).
  3. Respondent's principal Garrett T. Whitmore on the Board of Trustees of the Minnesota ADR Ethics Institute (governing body over the arbitrator's advisory board) — R-17(a)(ii)/(iv); Moderate-to-Strong.
  4. Arbitrator and lead counsel Dominic Hargrave were CLE co-panelists on a directly germane topic (Oct. 14, 2023) — R-17(a)(ii)/(iv); Moderate (stronger in combination).
  5. Omission of the pending *Halcyon Biotech* matter plus multiple completed matters; repeat-appointment/economic-dependence pattern (B&T = 45% of docket, 77.8% win rate, ~48% of income, ~67% of pending fees) — R-17(a)(iii); Moderate-to-Strong (completeness) / Moderate (bias inference).
  - Secondary: Lakeview affiliation disclosed without its financial/structural terms — Lower-Moderate.
- Provides a cumulative assessment (undisclosed ties reach key actors on **both** sides; appearance standard governs; substantial post-award vacatur risk).
- Recommends: (1) immediate R-17(d) supplemental-disclosure request on all five categories; (2) be prepared to file a formal R-18 challenge by June 24; (3) invite voluntary withdrawal under R-18(c); (4) strategic posture noting the Respondent's strongest ground (Ground 2) versus the Claimant's strong grounds (3 and 5); (5) preserve FAA § 10(a)(2) rights.

## Notes on source reconciliation
- The appointment-data spreadsheet's summary row tallies "five" undisclosed matters, but a row-by-row reconciliation against the arbitrator's seven disclosed matters identifies seven completed matters plus the pending *Halcyon Biotech* matter; the memo relies on the verifiable row-level data and flags the discrepancy.
- The entity memo counts four Fielding Marsh matters while the spreadsheet counts five (one settled); the memo uses the spreadsheet's five-total/four-adjudicated figures, consistent with the 25% FM win rate in both sources.

## Method
Drafted the memo in markdown, generated the .docx via the docx skill's `generate_from_md.py` (Pandoc), and ran `validate.py` (ZIP integrity, XML well-formedness, relationship consistency) — passed with exit code 0.